Cited by 1,987Cancer-related Molecular PathwaysCell death mechanisms and regulationPI3K/AKT/mTOR signaling in cancer

The DOI matches its Crossref record; 60 of the 70 references it cites were found in a registry or an index.

The p53 proto-oncogene can act as a suppressor of transformation

Finlay, Cathy A., Hinds, Philip W., Levine, Arnold J.·1989·Cell

Open this paper in CoChat — free account

Abstract

DNA clones of the wild-type p53 proto-oncogene inhibit the ability of E1A plus ras or mutant p53 plus ras-activated oncogenes to transform primary rat embryo fibroblasts. The rare clones of transformed foci that result from E1A plus ras plus wild-type p53 triple transfections all contain the p53 DNA in their genome, but the great majority fail to express the p53 protein. The three cell lines derived from such foci that express p53 all produce mutant p53 proteins with properties similar or identical to transformation-activated p53 proteins. The p53 mutants selected in this fashion (transformation in vitro) resemble the p53 mutants selected in tumors (in vivo). These results suggest that the p53 proto-oncogene can act negatively to block transformation.

Integrity signals

Registry

Crossref · 10.1016/0092-8674(89)90045-7

Cites

60 of 60 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

A new technique for the assay of infectivity of human adenovirus 5 DNA
Graham, F. L., & van der Eb, A. J. (1973) · Virology · doi:10.1016/0042-6822(73)90341-3 · Cited by 9,302
A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma
Friend, S. H., Bernards, R., Rogelj, S., Weinberg, R. A., Rapaport, J. M., Albert, D. M., & Dryja, T. P. (1986) · Nature · doi:10.1038/323643a0 · Cited by 2,948
Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes
Land, H., Parada, L. F., & Weinberg, R. A. (1983) · Nature · doi:10.1038/304596a0 · Cited by 2,804
Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter.
Southern, P. J., & Berg, P. R. (1982) · PubMed · Cited by 2,740
T antigen is bound to a host protein in SY40-transformed cells
Lane, D. P., & Crawford, L. V. (1979) · Nature · doi:10.1038/278261a0 · Cited by 2,456
Characterization of a 54K Dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells
Linzer, D. I. H., & Levine, A. J. (1979) · Cell · doi:10.1016/0092-8674(79)90293-9 · Cited by 1,814
Self-citation
SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene
DeCaprio, J. A., Ludlow, J. W., Figge, J., Shew, J.-Y., Huang, C.-M., Lee, W.-H., Marsilio, E., Paucha, E., & Livingston, D. M. (1988) · Cell · doi:10.1016/0092-8674(88)90559-4 · Cited by 1,459
Human Retinoblastoma Susceptibility Gene: Cloning, Identification, and Sequence
Lee, W., Bookstein, R., Hong, F., Young, L.-J., Shew, J., & Lee, E. Y.-H. P. (1987) · Science · doi:10.1126/science.3823889 · Cited by 1,417
Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product
Whyte, P., Buchkovich, K. J., Horowitz, J. M., Friend, S. H., Raybuck, M., Weinberg, R. A., & Harlow, E. (1988) · Nature · doi:10.1038/334124a0 · Cited by 1,403
Adenovirus early region 1A enables viral and cellular transforming genes to transform primary cells in culture
Ruley, H. E. (1983) · Nature · doi:10.1038/304602a0 · Cited by 1,248

Show all 70 references

Sorted by citations

Items 301–400 of 999

Update on Human Polyomaviruses and Cancer
Gjoerup, O. V., & Chang, Y. (2010) · Advances in cancer research · doi:10.1016/s0065-230x(10)06001-x · Cited by 142
Alterations of the p53 gene in nasopharyngeal carcinoma
Effert, P. J., McCoy, R., Abdel‐Hamid, M., Flynn, K., Zhang, Q., Busson, P., Tursz, T., Liu, E., & Raab‐Traub, N. (1992) · Journal of Virology · doi:10.1128/jvi.66.6.3768-3775.1992 · Cited by 137
The p53 protein family and radiation sensitivity: Yes or no?
Cuddihy, A. R., & Bristow, R. G. (2004) · Cancer and Metastasis Reviews · doi:10.1023/b:canc.0000031764.81141.e4 · Cited by 137
Physical and Functional Interaction between Wild-Type p53 and mdm2 Proteins
Haines, D. S., Landers, J. E., Engle, L. J., & George, D. L. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.2.1171 · Cited by 136
ANX7, a candidate tumor suppressor gene for prostate cancer
Srivastava, M., Bubendorf, L., Srikantan, V., Fossom, L. H., Nolan, L., Glasman, M., Leighton, X., Fehrle, W., Pittaluga, S., Raffeld, M. A., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.071055798 · Cited by 135
Role of the retinoblastoma gene in the initiation and progression of human cancer.
Benedict, W. F., Xu, H., Hu, S., & Takahashi, R. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114575 · Cited by 135
Repression of endogenous p53 transactivation function in HeLa cervical carcinoma cells by human papillomavirus type 16 E6, human mdm-2, and mutant p53
Hoppe‐Seyler, F., & Butz, K. (1993) · Journal of Virology · doi:10.1128/jvi.67.6.3111-3117.1993 · Cited by 134
Suppression of growth in vitro and tumorigenicity in vivo of human carcinoma cell lines by transfectedp16INK4
Spillare, E. A., Okamoto, A., Hagiwara, K., Demetrick, D. J., Serrano, M., Beach, D., & Harris, C. C. (1996) · Molecular Carcinogenesis · doi:10.1002/(sici)1098-2744(199605)16:1 · Cited by 36
TP53 Gene Mutations and 17p Deletions in Human Astrocytomas
Chung, R. Y., Whaley, J. M., Kley, N., Anderson, K., Louis, D. N., Menon, A. G., Hettlich, C., Freiman, R. N., Hedley‐Whyte, E. T., Martuza, R. L., et al. (1991) · Genes Chromosomes and Cancer · doi:10.1002/gcc.2870030502 · Cited by 134
New strategies are needed in diffuse malignant mesothelioma
Sridhar, K. S., Doria, X., Raub, W. A., Thurer, R. J., & Saldana, M. J. (1992) · Cancer · doi:10.1002/1097-0142(19921215)70:12 · Cited by 108
Analysis of the anti-p53 antibody response in cancer patients.
Labrecque, S., Naor, N., Thomson, D. M., & Matlashewski, G. (1993) · PubMed · Cited by 134
Immunohistochemical and molecular analysis of p53, MDM2, proliferating cell nuclear antigen and Ki67 in benign and malignant peripheral nerve sheath tumours
Kindblom, L. G., Ahld�n, M., Meis‐Kindblom, J. M., & Stenman, G. (1995) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/bf00203733 · Cited by 133
Cytotoxic effects of Coptis chinensis and Epimedium sagittatum extracts and their major constituents (berberine, coptisine and icariin) on hepatoma and leukaemia cell growth
Lin, C., Ng, L., Hsu, F.-F., Shieh, D., & Chiang, L. (2004) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2004.03951.x · Cited by 132
Tumor Suppressor Genes in Breast Cancer
Oliveira, A. M., Ross, J. S., & Fletcher, J. A. (2005) · Pathology Patterns Reviews · doi:10.1309/5xw3l8lu445qwgqr · Cited by 134
p53: The Attractive Tumor Suppressor in the Cancer Research Field
Ozaki, T., & Nakagawara, A. (2010) · BioMed Research International · doi:10.1155/2011/603925 · Cited by 138
Structural and functional analysis of oncogenes and tumor suppressor genes in adult T-cell leukemia/lymphoma shows frequent p53 mutations
Cesarman, E., Chadburn, A., Inghirami, G., Gaïdano, G., & Knowles, D. (1992) · Blood · doi:10.1182/blood.v80.12.3205.3205 · Cited by 131
Mutant p53 can induce tumorigenic conversion of human bronchial epithelial cells and reduce their responsiveness to a negative growth factor, transforming growth factor beta 1.
Gerwin, B. I., Spillare, E. A., Forrester, K., Lehman, T. A., Kispert, J., Welsh, J. A., Pfeifer, A. M. A., Lechner, J. F., Baker, S. J., & Vogelstein, B. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.7.2759 · Cited by 131
p53 in node-negative breast carcinoma: an immunohistochemical study of epidemiologic risk factors, histologic features, and prognosis.
Rosen, P. P., LESSER, M. L., Arroyo, C. D., Cranor, M. L., Borgen, P. I., & Norton, L. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.4.821 · Cited by 131
p53 Protein alterations in human testicular cancer including pre‐invasive intratubular germ‐cell neoplasia
́, J. B., Bartek, J. J., Lukáŝ, J., Vojtěšek, B., Stašková, Z., Rejthar, A., Kovařík, J., Midgley, C., & Lane, D. P. (1991) · International Journal of Cancer · doi:10.1002/ijc.2910490209 · Cited by 131
Nuclear protein phosphorylation and growth control
Meek, D. W., & Street, A. J. (1992) · Biochemical Journal · doi:10.1042/bj2870001 · Cited by 132
Hereditary breast cancer
Robson, M. E., Boyd, J. A., Borgen, P. I., & Cody, H. S. (2001) · Current Problems in Surgery · doi:10.1016/s0011-3840(01)70035-4 · Cited by 133
Hepatitis B virus integration event in human chromosome 17p near the p53 gene identifies the region of the chromosome commonly deleted in virus-positive hepatocellular carcinomas.
Slagle, B. L., Zhou, Y.-Z., & Butel, J. S. (1991) · PubMed · Cited by 130
Perianal Bowen's disease
Marchesa, P., Fazio, V. W., Oliart, S., Goldblum, J. R., & Lavery, I. C. (1997) · Diseases of the Colon & Rectum · doi:10.1007/bf02050810 · Cited by 129
Risk of hepatocellular carcinoma in patients with cirrhosis in Japan. Analysis of infectious hepatitis viruses
Kato, Y., Nakata, K., Nagataki, S., Omagari, K., FURUKAWA, R., KUSUMOTO, Y., Mori, I., TAJIMA, H., Tanioka, H., & Yano, M. (1994) · Cancer · doi:10.1002/1097-0142(19941015)74:8 · Cited by 151
The isolation of an RNA aptamer targeting to p53 protein with single amino acid mutation
Chen, L., Rashid, F., Shah, A., Awan, H. M., Wu, M., Liu, A., Wang, J., Zhu, T., Luo, Z., & Shan, G. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1502159112 · Cited by 126
Gene mutations and increased levels of p53 protein in human squamous cell carcinomas and their cell lines
Burns, J. E., Baird, M., Clark, L., Burns, P. A., Edington, K. G., Chapman, C., Mitchell, R. T., Robertson, G., Soutar, D. S., & Parkinson, E. K. (1993) · British Journal of Cancer · doi:10.1038/bjc.1993.238 · Cited by 127
Mutation of the p53 gene in human acute myelogenous leukemia
Slingerland, J., Minden, M., & Benchimol, S. (1991) · Blood · doi:10.1182/blood.v77.7.1500.bloodjournal7771500 · Cited by 130
Evaluation of transgenic mouse bioassays for identifying carcinogens and noncarcinogens
Tennant, R. W., Spalding, J. W., & French, J. E. (1996) · Mutation Research/Reviews in Genetic Toxicology · doi:10.1016/s0165-1110(96)90016-0 · Cited by 130
P53 aggregation, interactions with tau, and impaired DNA damage response in Alzheimer’s disease
Farmer, K. M., Ghag, G., Puangmalai, N., Montalbano, M., Bhatt, N. N., & Kayed, R. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-01012-6 · Cited by 130
Regulation of synoviocyte proliferation, apoptosis, and invasion by the p53 tumor suppressor gene.
Aupperle, K. R., Boyle, D. L., Hendrix, M. J. C., Seftor, E. A., Zvaifler, N. J., Barbosa, M. S., & Firestein, G. S. (1998) · Europe PMC (PubMed Central) · Cited by 125
Control of cell migration: a tumour suppressor function for p53?
Roger, L., Gadéa, G., & Roux, P. (2006) · Biology of the Cell · doi:10.1042/bc20050058 · Cited by 132
Interference with p53 protein inhibits hematopoietic and muscle differentiation.
Soddu, S., Blandino, G., Scardigli, R., Coen, S., Marchetti, A., Rizzo, M. G., Bossi, G., Cimino, L., Crescenzi, M., & Sacchi, A. (1996) · The Journal of Cell Biology · doi:10.1083/jcb.134.1.193 · Cited by 129
A temperature‐sensitive mutant of human p53.
Zhang, W., Guo, X. Y., Hu, G., Liu, W. B., Shay, J. W., & Deisseroth, A. B. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06543.x · Cited by 127
Casein kinase II and the tumor suppressor protein P53 associate in a molecular complex that is negatively regulated upon P53 phosphorylation.
Filhol, O., Baudier, J., Delphin, C., Loue-Mackenbach, P., CHAMBAZ, E. M., & Cochet, C. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)36725-0 · Cited by 127
Cytogenetics of colorectal adenocarcinomas
Muleris, M., Salmon, R.-J., & Dutrillaux, B. (1990) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(90)90100-o · Cited by 126
Expression of p53 and 17p allelic loss in colorectal carcinoma.
Cunningham, J. M., Lust, J. A., Schaid, D. J., Bren, G. D., Carpenter, H. A., Rizza, E. H., Kovach, J. S., & Thibodeau, S. N. (1992) · PubMed · Cited by 126
Mutant p53—the commonest genetic abnormality in human cancer?
Harris, A. L. (1990) · The Journal of Pathology · doi:10.1002/path.1711620103 · Cited by 126
Haplo‐insufficiency: a driving force in cancer
Berger, A. H., & Pandolfi, P. P. (2010) · The Journal of Pathology · doi:10.1002/path.2800 · Cited by 129
How the Rb tumor suppressor structure and function was revealed by the study of Adenovirus and SV40
DeCaprio, J. A. (2009) · Virology · doi:10.1016/j.virol.2008.12.010 · Cited by 126
Tetramer formation of tumor suppressor protein p53: Structure, function, and applications
Kamada, R., 戸口, 侑., Nomura, T., Imagawa, T., & Sakaguchi, K. (2015) · Biopolymers · doi:10.1002/bip.22772 · Cited by 127
Neoplasia of the ampulla of Vater. Ki-ras and p53 mutations.
Scarpa, A., Capelli, P., Zamboni, G., Oda, T., Mukai, K., Bonetti, F., Martignoni, G., Iacono, C., Serio, G., & Hirohashi, S. (1993) · PubMed Central · Cited by 124
The adenovirus E4orf6 protein can promote E1A/E1B-induced focus formation by interfering with p53 tumor suppressor function
Nevels, M. M., Rubenwolf, S., Spruß, T., Wolf, H. J., & Dobner, T. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.4.1206 · Cited by 124
Regulation of p53-dependent apoptosis, transcriptional repression, and cell transformation by phosphorylation of the 55-kilodalton E1B protein of human adenovirus type 5
Teodoro, J. G., & Branton, P. E. (1997) · Journal of Virology · doi:10.1128/jvi.71.5.3620-3627.1997 · Cited by 124
Identification of intronic point mutations as an alternative mechanism for p53 inactivation in lung cancer.
Takahashi, T., D'Amico, D., Chiba, I., Buchhagen, D. L., & Minna, J. D. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114710 · Cited by 124
The ability of simian virus 40 large T antigen to immortalize primary mouse embryo fibroblasts cosegregates with its ability to bind to p53
Zhu, J., Abate, M., Rice, P. W., & Cole, C. N. (1991) · Journal of Virology · doi:10.1128/jvi.65.12.6872-6880.1991 · Cited by 127
Mutations in the p53 tumor suppressor gene in human cutaneous squamous cell carcinomas
Pierceall, W. E., Mukhopadhyay, T., Goldberg, L. H., & Ananthaswamy, H. N. (1991) · Molecular Carcinogenesis · doi:10.1002/mc.2940040606 · Cited by 124
Functional Domains of Wild-Type and Mutant p53 Proteins Involved in Transcriptional Regulation, Transdominant Inhibition, and Transformation Suppression
Unger, T., Mietz, J. A., Scheffner, M., Yee, C., & Howley, P. M. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.9.5186 · Cited by 127
Loss of heterozygosity and p53 gene mutations in breast cancer.
Deng, G., Chen, L. C., Schott, D. R., Thor, A. D., Bhargava, V., Ljung, B., Chew, K., & Smith, H. S. (1994) · PubMed · Cited by 124
Tumor progression in hepatocellular carcinoma may be mediated by p53 mutation.
Tanaka, S., Toh, Y., Adachi, E., Matsumata, T., Mori, R., & Sugimachi, K. (1993) · PubMed · Cited by 123
The molecular biology of esophageal and gastric cancer and their precursors: Oncogenes, tumor suppressor genes, and growth factors
Stemmermann, G. N., Heffelfinger, S. C., Noffsinger, A. E., Hui, Y. Z., Miller, M. A., & Fenoglio‐Preiser, C. M. (1994) · Human Pathology · doi:10.1016/0046-8177(94)90056-6 · Cited by 122
Polymorphism in the tumor necrosis factor-? promotor region and in the heat shock protein 70 genes associated with malignant tumors
Chouchane, L., Ahmed, S. B., Baccouche, S., & Remadi, S. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19971015)80:8 · Cited by 103
d -Limonene sensitizes docetaxel-induced cytotoxicity in human prostate cancer cells: Generation of reactive oxygen species and induction of apoptosis
Bishayee, A., & Rabi, T. (2009) · Journal of Carcinogenesis · doi:10.4103/1477-3163.51368 · Cited by 121
Li‐Fraumeni syndrome: a paradigm for the understanding of hereditary cancer predisposition
Valdez, J. M., Nichols, K. E., & Kesserwan, C. A. (2016) · British Journal of Haematology · doi:10.1111/bjh.14461 · Cited by 124
Molecular epidemiology and carcinogenesis: endogenous and exogenous carcinogens
Hussain, S. P., & Harris, C. C. (2000) · Mutation Research/Reviews in Mutation Research · doi:10.1016/s1383-5742(00)00015-6 · Cited by 120
G1/S control of anchorage-independent growth in the fibroblast cell cycle.
Guadagno, T. M., & Assoian, R. K. (1991) · The Journal of Cell Biology · doi:10.1083/jcb.115.5.1419 · Cited by 120
The prevalence of colonic polyps in acromegaly: a colonoscopic and pathological study in 103 patients
Delhougne, B., Deneux, C., Abs, R., Chanson, P., Fierens, H., Laurent‐Puig, P., Duysburgh, I., Stevenaert, A., Tabarin, A., Delwaide, J., et al. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.80.11.3223 · Cited by 119
Safety Evaluation of Ad5CMY- p53 In Vitro and In Vivo
Zhang, W., Alemany, R., Wang, J., Koch, P. E., Ordóǹez, N. G., & Roth, J. A. (1995) · Human Gene Therapy · doi:10.1089/hum.1995.6.2-155 · Cited by 119
Abnormalities of the retinoblastoma gene in the pathogenesis of acute leukemia
Ahuja, H., Jat, P., Foti, A., Bar‐Eli, M., & Cline, M. (1991) · Blood · doi:10.1182/blood.v78.12.3259.3259 · Cited by 119
Somatic p53 mutations in human breast carcinomas in an Icelandic population: a prognostic factor.
Thorlacius, S., Børresen‐Dale, A., & Eyfjörd, J. E. (1993) · PubMed · Cited by 119
p53 and Cell Cycle Effects After DNA Damage
Senturk, E., & Manfredi, J. J. (2012) · Methods in molecular biology · doi:10.1007/978-1-62703-236-0_4 · Cited by 115
Intestinal mucositis: the role of the Bcl-2 family, p53 and caspases in chemotherapy-induced damage
Bowen, J. M., Gibson, R. J., Cummins, A. G., & Keefe, D. M. K. (2006) · Supportive Care in Cancer · doi:10.1007/s00520-005-0004-7 · Cited by 119
p53 as a target for cancer vaccines: recombinant canarypox virus vectors expressing p53 protect mice against lethal tumor cell challenge.
Roth, J., Dittmer, D. P., Réa, D., Tartaglia, J., Paoletti, E., & Levine, A. J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.10.4781 · Cited by 118
Self-citation
p53: Twenty five years understanding the mechanism of genome protection
Gómez-Lázaro, M., Fernández-Gómez, F.-J., & Jordán, J. (2004) · Journal of Physiology and Biochemistry · doi:10.1007/bf03167075 · Cited by 119
Tumourigenesis associated with the p53 tumour suppressor gene
Chang, F., Syrjänen, S., Tervahauta, A. I., & Syrjänen, K. J. (1993) · British Journal of Cancer · doi:10.1038/bjc.1993.404 · Cited by 117
Synergy between the Mos/Mitogen-Activated Protein Kinase Pathway and Loss of p53 Function in Transformation and Chromosome Instability
Fukasawa, K., & Woude, G. F. V. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.1.506 · Cited by 117
Molecular genetic demonstration of the diverse evolution of Richter's syndrome (chronic lymphocytic leukemia and subsequent large cell lymphoma)
Matolcsy, A., Inghirami, G., & Knowles, D. (1994) · Blood · doi:10.1182/blood.v83.5.1363.1363 · Cited by 116
Retroviral Mutagenesis of Cellular Oncogenes: A Review with Insights into the Mechanisms of Insertional Activation
Kung, H. J., Boerkoel, C. F., & Carter, T. H. (1991) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-76524-7_1 · Cited by 117
MiRNA-34 intrinsically links p53 tumor suppressor and Wnt signaling
Cha, Y. H., Kim, N. H., Park, C., Lee, I., Kim, H. S., & Yook, J. I. (2012) · Cell Cycle · doi:10.4161/cc.19618 · Cited by 115
Heat Shock Protein 84 Forms a Complex with Mutant p53 Protein Predominantly within a Cytoplasmic Compartment of the Cell
Sepehrnia, B., Paz, I. B., Dasgupta, G., & Momand, J. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.25.15084 · Cited by 115
Tumor suppressor genes, growth factor genes, and oncogenes in hepatitis B virus‐associated hepatocellular carcinoma
Tabor, E. (1994) · Journal of Medical Virology · doi:10.1002/jmv.1890420406 · Cited by 116
The Role of the p53 Tumor Suppressor Gene in Squamous Cell Carcinoma of the Head and Neck
Field, J. K., Pavelić, Z. P., Spandidos, D. A., Stambrook, P. J., Jones, A., & Gluckman, J. L. (1993) · Archives of Otolaryngology - Head and Neck Surgery · doi:10.1001/archotol.1993.01880220064009 · Cited by 115
p53 Expression in brain after middle cerebral artery occlusion in the rat
Chopp, M., Li, Y., Zhang, Z. G., & Freytag, S. O. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)91859-o · Cited by 115
Inactivation of the Cellular p53 Gene Is a Common Feature of Friend Virus-Induced Erythroleukemia: Relationship of Inactivation to Dominant Transforming Alleles
Munroe, D. G., Peacock, J. W., & Benchimol, S. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.7.3307 · Cited by 117
Protein Kinase C δ Induces Transcription of the TP53 Tumor Suppressor Gene by Controlling Death-Promoting Factor Btf in the Apoptotic Response to DNA Damage
Liu, H., Lu, Z., Miki, Y., & Yoshida, K. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01126-07 · Cited by 114
Expression of p53 mutant nuclear phosphoprotein in oral carcinoma and potentially malignant oral lesions
Warnakulasuriya, S., & Johnson, N. W. (1992) · Journal of Oral Pathology and Medicine · doi:10.1111/j.1600-0714.1992.tb01028.x · Cited by 114
E1B 55-Kilodalton-Associated Protein: a Cellular Protein with RNA-Binding Activity Implicated in Nucleocytoplasmic Transport of Adenovirus and Cellular mRNAs
Gabler, S., SCHÜTT, H., Groitl, P., Wolf, H. J., Shenk, T. E., & Dobner, T. (1998) · Journal of Virology · doi:10.1128/jvi.72.10.7960-7971.1998 · Cited by 114
Expression of Wild-Type p53 Is Not Compatible with - Continued Growth of p53-Negative Tumor Cells
Johnson, P., Gray, D. A., Mowat, M. R. A., & Benchimol, S. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.1.1 · Cited by 112
Early endosome membrane dynamics characterized by flow cytometry
Chavrier, P., van der Sluijs, P., Mishal, Z., Nagelkerken, B., & Gorvel, J. (1997) · Cytometry · doi:10.1002/(sici)1097-0320(19970901)29:1 · Cited by 26
Regulation of the p53 protein by the MDM2 oncoprotein--thirty-eighth G.H.A. Clowes Memorial Award Lecture.
Freedman, D. A., & Levine, A. J. (1999) · PubMed · Cited by 114
Self-citation
The transforming activity of simian virus 40 large tumor antigen
Manfredi, J. J., & Prives, C. L. (1994) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(94)90006-x · Cited by 113
p53 Immunostaining Positivity Is Associated With Reduced Survival and Is Imperfectly Correlated With Gene Mutations in Resected Non-small Cell Lung Cancer
Carbone, D. P., Mitsudomi, T., Chiba, I., Piantadosi, S., Rusch, V. W., Nowak, J. A., McIntire, D. D., Slamon, D. J., Gazdar, A. F., & Minna, J. D. (1994) · CHEST Journal · doi:10.1378/chest.106.6_supplement.377s · Cited by 113
Epithelial Ovarian Cancer
Morgan, R. J., Alvarez, R. D., Armstrong, D. K., Boston, B., Burger, R. A., Chen, L.-M., Copeland, L. J., Crispens, M. A., Gershenson, D. M., Gray, H. J., et al. (2011) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2011.0008 · Cited by 112
The Tumor Suppressor p53 Regulates Its Own Transcription
Deffie, A. M., Wu, H., Reinke, V., & Lozano, G. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.6.3415 · Cited by 113
Human Cytomegalovirus Immediate-Early Protein IE2 Tethers a Transcriptional Repression Domain to p53
Tsai, H.-L., Kou, G. H., Chen, S.-C., Wu, C., & Lin, Y.-S. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.7.3534 · Cited by 113
p53 and the Li-Fraumeni syndrome
Malkin, D. M. (1994) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(94)90014-0 · Cited by 116
Negative effects of wild-type p53 and s-Myc on cellular growth and tumorigenicity of glioma cells
Asai, A., Miyagi, Y., Sugiyama, A., Gamanuma, M., Hong, S., Takamoto, S., Nomura, K., Matsutani, M., Takakura, K., & Kuchino, Y. (1994) · Journal of Neuro-Oncology · doi:10.1007/bf01053280 · Cited by 113
Analysis of Wild-Type and Mutant p21 WAF-1 Gene Activities
Lin, J., Reichner, C., Wu, X., & J. Levine, A. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.4.1786 · Cited by 111
The helix-loop-helix containing transcription factor USF binds to and transactivates the promoter of the p53 tumor suppressor gene
Reisman, D., & Rotter, V. (1993) · Nucleic Acids Research · doi:10.1093/nar/21.2.345 · Cited by 111
Clinical utility of the immunocytochemical detection of p53 protein in cytological specimens.
Dowell, S. P., Wilson, P., Derias, N. W., Lane, D. P., & Hall, P. A. (1994) · PubMed · Cited by 110
A DNA binding domain is contained in the C-terminus ofwild typep53 protein
Foord, O., Bhattacharya, P., Reich, Z., & Rotter, V. (1991) · Nucleic Acids Research · doi:10.1093/nar/19.19.5191 · Cited by 111
P53 activity is essential for normal development in Xenopus
Wallingford, J. B., Seufert, D. W., Virta, V. C., & Vize, P. D. (1997) · Current Biology · doi:10.1016/s0960-9822(06)00333-2 · Cited by 110
Human chromosome 11 contains two different growth suppressor genes for embryonal rhabdomyosarcoma.
Loh, W. E., Scrable, H. J., Livanos, E., Arboleda, M. J., Cavenee, W. K., Oshimura, M., & Weissman, B. E. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.5.1755 · Cited by 110
CHASING THE CANCER DEMON
Knudson, A. G. (2000) · Annual Review of Genetics · doi:10.1146/annurev.genet.34.1.1 · Cited by 110
Tumour suppressor gene products, proliferation, and differentiation markers in lung neuroendocrine neoplasms
Barbareschi, M., Girlando, S., Mauri, F. A., Arrigoni, G., Laurino, L., Palma, P., & Doglioni, C. (1992) · The Journal of Pathology · doi:10.1002/path.1711660405 · Cited by 110
The large tumor antigen of simian virus 40 encodes at least two distinct transforming functions
Srinivasan, A., Peden, K., & Pipas, J. M. (1989) · Journal of Virology · doi:10.1128/jvi.63.12.5459-5463.1989 · Cited by 110
Phosphorylation of transcriptional factors and cell-cycle-dependent proteins by casein kinase II
Meisner, H. M., & Czech, M. (1991) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(91)90076-b · Cited by 108
Changes in O-Linked N-Acetylglucosamine (O-GlcNAc) Homeostasis Activate the p53 Pathway in Ovarian Cancer Cells
de Queiroz, R. M., Madan, R., CHIEN, J. R., Dias, W. B., & Slawson, C. M. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.734533 · Cited by 109
p73 or p53 Directly Regulates Human p53 Transcription to Maintain Cell Cycle Checkpoints
Wang, S., & El‐Deiry, W. S. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0511 · Cited by 109
Biochemical and biological differences between E7 oncoproteins of the high- and low-risk human papillomavirus types are determined by amino-terminal sequences
Münger, K., Yee, C., Phelps, W. C., Pietenpol, J. A., Moses, H. L., & Howley, P. M. (1991) · Journal of Virology · doi:10.1128/jvi.65.7.3943-3948.1991 · Cited by 108
Aberrant hnRNP K expression: All roads lead to cancer
Gallardo, M., Aitken, M. J. L., Zhang, X., Hu, P. C., Bueso-Ramos, C., & Post, S. M. (2016) · Cell Cycle · doi:10.1080/15384101.2016.1164372 · Cited by 107

Authors: Finlay, C. A., Hinds, P. W., & Levine, A. J.
Affiliations: Princeton University (US)
ORCID: Hinds, Philip W.
Levine, Arnold J.
Venue: Cell
Publisher: Elsevier BV
Published: 1989-06
Volume: 57
Issue: 7
Pages: 1083-1093
ISSN: 0092-8674 (ISSN-L)
DOI: 10.1016/0092-8674(89)90045-7
OpenAlex: W2163565167
Cited by: 1,987
References: 70
Citations by year: 2026: 14 · 2025: 12 · 2024: 25 · 2023: 27 · 2022: 20 · 2021: 34 · 2020: 37 · 2019: 31 · 2018: 29 · 2017: 29 · 2016: 28 · 2015: 12 · 2014: 28 · 2013: 26 · 2012: 38
FWCI: 79.38
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Cell (publishedVersion)
PubMed (publishedVersion)
Funders: National Cancer Institute (P01CA041086, P01-CA41086-03)
Topics: Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
Keywords: tumor suppressor, oncogenic transformation, adenovirus E1A, oncogenic Ras, mutant p53, p53 expression, rat embryo fibroblasts, transformed foci, tumor suppressor function
MeSH terms: Animals, Antigens, Polyomavirus Transforming, Cell Line, Cell Transformation, Neoplastic, Cells, Cultured, Gene Expression Regulation, Neoplasm Proteins, Oncogene Proteins, Viral, Phosphoproteins, Proto-Oncogene Proteins, Genes, ras, Transfection, Tumor Suppressor Protein p53, Adenovirus Early Proteins, Mice, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The p53 proto-oncogene can act as a suppressor of transformation

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks